Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 MilliporeSigma Launches BioReliance Characterization Portfolio | Contract Pharma

What are you searching for?

Sign in
Breaking News

MilliporeSigma Launches BioReliance Characterization Portfolio

New suite of tests provides critical information biologic manufacturers need to design production processes

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

MilliporeSigma has launched its BioReliance Product Characterization Portfolio of tests for quality assessment of biologics. This new suite of tests provides critical information biologic manufacturers need to design production processes. The purity, safety and efficacy of a drug must be identified and continuously monitored in order to support development and meet regulatory requirements necessary for commercialization. Manufacturers can better understand their molecule’s function through comparison of structure and activity. 
 
This portfolio of assays enables the characterization of mAbs, including physicochemical and immunochemical properties, biological activity, stability and purity as outlined in the ICH Q6B guidelines, as well as EMEA and FDA regulatory requirements. Also, capabilities, such as hydrogen-deuterium exchange technology and highly sensitive surface plasmon resonance instrumentation, are available.
 
BioReliance services offer risk-mitigating approaches, critical testing services and customized solutions.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics